Soleus Capital Management, L.P. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2023$508,800
-90.4%
320,000
-94.3%
0.06%
-92.1%
Q3 2022$5,308,000
+438.3%
5,587,789
+5488.2%
0.72%
+305.1%
Q1 2021$986,000
-33.1%
99,992
-26.5%
0.18%
-8.2%
Q4 2020$1,474,000
-60.7%
135,992
-62.7%
0.19%
-90.2%
Q3 2020$3,753,000
-17.8%
364,349
+66.6%
1.99%
-23.6%
Q2 2020$4,566,000
+48.9%
218,723
-30.3%
2.60%
-27.1%
Q1 2020$3,067,000
-22.3%
313,900
-8.4%
3.57%
-6.3%
Q4 2019$3,949,000342,8003.81%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders